Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2626-2636

  Holmström, Tim H ^a,b   Chow, Sek C ^c   Elo, Iina ^a,b   Coffey, Eleanor T ^b   Orrenius, Sten ^d   Sistonen, Lea ^a   Eriksson, John E ^a,e  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELL STIMULATION; COMPETITIVE INHIBITION; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ANTIGENS, CD95; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0032521027     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klaus, M. Li-Weber, S. Richard, J. Dhein, B. C. Trauth, H. Ponsting, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267:10709.
2. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen can mediate apoptosis. Cell 66:233.
3. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
4. Trauth., B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Möller, W. Falk, K.-M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
5. Weis, M., J. Schlegel, G. E. N. Kass, T. H. Holmström, I. Peters, J. E. Eriksson, S. Orrenius, and S. C. Chow. 1995. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T-lymphocytes. Exp. Cell Res. 219:699.
6. Ni, R., Y. Tomita, K. Matsuda, A. Ichiara, K. Ishimura, J. Ogasawara, and S. Nagata. 1994. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 21:332.
7. Suzuki, A., M. Enari, Y. Eguchi, A. Matsuzawa, S. Nagata, Y. Tsujimoto, and T. Iguchi. 1996. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during estrous cycle. EMBO J. 15:211.
8. Chinnaiyan, A. M., and V. M. Dixit. 1996. The cell death machine. Curr. Biol. 6:555.
9. Peter, M. E., F. C. Kischkel, S. Hellbardt, A. M. Chinnaiyan, P. H. Krammer, and V. M. Dixit. 1996. CD95 (APO-1/Fas)-associating signalling proteins. Cell Death Differ. 3:161.
10. Schlegel, J., I. Peters, S. Orrenius, D. K. Miller, N. A. Thornberry, T.-T. Yamin, and D. W. Nicholson. 1996. CPP32/Apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 4:1841.
11. Song, Q., and M. F. Lavin. 1993. Calyculin A, a potent inhibitor of phosphatase-1 and -2A. prevents apoptosis. Biochem. Biophys. Res. Commun. 190:47.
12. Yousefi, S., D. R. Green, K. Blaser, and H. U. Simon. 1994. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. USA 91:10868.
13. McGahon, A. J., W. K. Nishioka, S. J. Martin, A. Mahboubi, T. G. Cotter, and D. R. Green. 1995. Regulation of the Fas apoptotic cell death pathway by Abl. J. Biol. Chem. 270:22625.
14. Schieven, G. L., A. F. Wahl, S. Myrdal, L. Grosmaire, and J. A. Ledbetter. 1995. Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine phosphatase inhibitor bis(maltolato)oxovanadium(IV). J. Biol. Chem. 270:20824.
15. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
16. Tian, Q., J.-L. Taupin, S. Elledge, M. Robertson, and P. Anderson. 1995. Fas-activated serine/threonine kinase phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182:865.
17. Aggarwal, B. B., S. Singh, R. LaPushin, and K. Totpal. 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5.
18. Owen-Shaub, L. B., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on hematopoietic tumors: levels of Fas/APO-1 and Bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580.
19. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889.
20. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus extracellular signal regulated kinase activation. Cell 80:179.
21. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326.
22. Cuvillier, O., G. Pirianov, B. Kleuser, P. G. Vanek, O. A. Coso, J. S. Gutkind, and S. Spiegel. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800.
23. Cano, E., and L. C. Mahadeva. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117.
24. Crews, C. M., and R. L. Erikson. 1992. Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product. Proc. Natl. Acad. Sci. USA 89:8205.
25. Wu, J., J. K. Harrison, L. A. Vincent, C. Haystead, T. A. J. Haystead, H. Michel, D. F. Hunt, K. R. Lynch, and T. W. Sturgill. 1993. Molecular structure of a protein-tyrosine/threonine kinase activating p42 mitogen activated protein (MAP) kinase: MAP kinase kinase. Proc. Natl. Acad. Sci. USA 90:173.
26. Casillas, A. M., K. Amaral, S. Chegini-Farahani, and A. E. Nel. 1993. Okadaic acid activates p42-mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: contrast with phorbol 12-myristate 13-acetate. Biochem. J. 290:545.
27. Mumby, M. C., and G. Walter. 1993. Protein serine/threonine phosphatases: structure, regulation, and function in cell growth. Physiol. Rev. 73:673.
28. Waskiewicz, A. J., and J. Cooper. 1995. Mitogen and stress response pathway: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell. Biol. 7:7981.
29. Chow, S. C., M. Weiss, G. E. N. Kass, T. H. Holmström, J. E. Enksson, and S. Orrenius. 1995. Involvement of multiple proteases during Fas-mediated apoptosis in T-lymphocytes. FEBS Lett. 364:134.
30. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78.
31. Nel, A. E., J. A. Ledbetter, K. Williams, P. Ho, B. Akerley, K. Franklin, and R. Katz. 1991. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase. Immunology 73:129.
32. Whithurst, C. E., T. G. Boulton, H. Cobb, and T. D. Geppert. 1992. Extracellular signal-regulated kinases in T cells: anti-CD3 and 4β-phorbol 12-myristate 13-acetate-induced phosphorylation and activation. J. Immunol. 148:3230.
33. Nel, A. E., C. Hanekom, A. Rheeder, K. Williams, S. Pollack, R. Katz, and GE. Landreth. 1990. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. J. Immunol. 144:2683.
34. lck. Tissue Antigens 46:155.
35. Hartsough, M. T., and K. M. Mulder. 1995. Transforming growth factor beta activation of p44 mapk in proliferating cultures of epithelial cells. J. Biol. Chem. 270:7117.
36. Chow, S. C., and S. Orrenius. 1994. Rapid cytoskeleton modifications in thymocytes induced by the immunotoxicant tributylin. Toxicol. Appl. Pharmacol. 127:19.
37. Fried, J., A. G. Perez, and B.-D. Clarkson. 1978. Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures, some pitfalls in staining and data analysis. J. Histochem. Cytochem. 2692:1.
38. Nicoletti, I., G. Migliorati, C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 13:271.
39. 2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 8:749.
40. Brown, D. G., X.-M. Sun, and G. M. Cohen. 1993. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 26:3037.
41. Alnemri, E. S., and G. J. Litwack. 1990. Activation of internucleosomal DNA cleavase in human CEM lymphocytes by glucocorticoid and novobiocin. J. Biol. Chem. 265:17323.
42. Lazebnik, Y. A., S. Cole, C. A. Cooke, G. W. Nelson, and W. C. Eamshaw. 1993. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 12:7.
43. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 46:27489.
44. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and N. O. Ann. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Nature 265:966.
45. Mansour, S. J., J. M. Candia, J. E. Matsuura, M. C. Manning, and N. G. Ahn. 1996. Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1. Biochemistry 35:15529.
46. Fagnani, R., and J. A. Braatz. 1980. Removal of phytohemagglutinin from conditioned medium by affinity chromatography. J. Immunol Methods 33:313.
47. Steller. 1995. Mechanisms and genes of cellular suicide. Science 267:1445.
48. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579.
49. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH a novel MORT/Fadd-interacting protease in Fas/APO-1 and TNF receptor induced cell death. Cell 85:803.
50. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817.
51. Copeland, K. F., A. G. Haaksma, J. Goudsmit, P. H. Krammer, and J. L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T-cell leukemia virus type 1 Tax. AIDS Res. Hum. Retroviruses 10:1259.
52. Gulbins, E., R. Bissonnette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, F. Lang, R. Kolesnick, A. Altman, and D. Green. 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341.
53. Holt, K. H., B. G. Kasson, and J. E. Pessin. 1996. Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase. Mol. Cell. Biol. 16:577.
54. Cerwenka, A., H. Kovar, O. Majdic, and W. Holler. 1996. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGFβ. J. Immunol. 156:459.
55. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90:10340.
56. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1995. Activation interferes with the APO-1 pathway in mature human T-cells. Int. Immunul. 5:625.
57. Parjis, L. V., A. Ibraghimov, and A. K. Abbas. 1996. The role of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
58. Memon, S. A., M. B. Moreno, D. Petrak, and C. M. Zacharuk. 1995. Bcl-2 blocks glucocorticoid-but not Fas-or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644.
59. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
60. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
61. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
62. Owen-Schaub, L. B., S. Yonchara, W. L. Crump, and E. A. Grimm. 1995. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
63. Alderson, M., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
64. Strasser, A. 1995. Death of a T cell. Nature 373:385.
65. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.